InvestorsHub Logo
icon url

hero86

01/04/10 6:24 PM

#2866 RE: kingmoni2003 #2865

ANX has enough cash for 24 months now @ 19MM extra jing. They state it's for marketing, so that tells me they must be pretty confident that their oncology device will get approved.. as written in the biomed report.

I'm a buyer here anywhere in the mid .20's.
icon url

cjstocksup

01/04/10 7:43 PM

#2881 RE: kingmoni2003 #2865

Read this report today, it will make you fell better. Today, the company announced today that it has signed agreements to purchase shares of its Series E convertible preferred stock pursuant to a registered direct offering to institutional investors, representing gross proceeds to ADVENTRX of approximately $19 million dollars.

In a huge tell about how the company is feeling about their chances, ADVENTRX says it plans to use the net proceeds from the offering to fund activities relating to the commercial launch of ANX-530, including acquiring or developing sales, marketing and distribution capabilities and the associated regulatory compliance infrastructure, and to continue the development of ANX-514 in the United States.

Compared to most biotechs with this much upside, ADVENTRX has a relatively low number of outstanding shares and a very small market cap.

They have no debt and at now least 24 months of cash on hand.

Also, ADVENTRX's costs do not include typical high dollar expensive clinical studies. ANX's clinical studies are understandably much, much lower.

In short, ANX is taking high profit drugs, improving delivery and presenting investors with a tremendous buying opportunity.

I believe this is a very solid company with an excellent chance of price share appreciation both in the very short and long term. Mike Burns is a former investment advisor with First Albany and Smith Barney. He now works in the pharmaceutical industry and is a contributor to BioMedReports. Disclosure: Long ANX

Copyright 2010 BAYSTREET NEWSWIRE
icon url

niter

01/04/10 11:23 PM

#2908 RE: kingmoni2003 #2865

I'm voting for your second option.He's f... a.Without second PR we should pass $1.25 before noon.IMO he was worry about a huge sell of for profit and didn't recognized that peeps will get panic.They try stop panic and it's a reason for third PR .To bad and to late .Nobody like to scoop the milk from the floor.Now we have to wait for $1 longer then we should.Long and probably strong:-)